Linda Cerbone

Improved outcomes in elderly patients with metastatic castration-resistant prostate cancer treated with the androgen receptor inhibitor enzalutamide: results from the phase III AFFIRM trial

Cora N. Sternberg, Johann S. de Bono, K.N. Chi et al. · Annals of Oncology · 2014 · 127 citations · Full text

Urology, Oncology, Elderly Patients +6

Phase 2 trial of dovitinib in patients with progressive FGFR3-mutated or FGFR3 wild-type advanced urothelial carcinoma

Matthew I. Milowsky, Christian Dittrich, Ignacio Durán et al. · European Journal of Cancer · 2014 · 111 citations

Urology, Genitourinary Cancer, Urothelial Carcinoma +6

Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors

Matteo Santoni, Alessandro Conti, Stefano Partelli et al. · Annals of Surgical Oncology · 2014 · 90 citations

Surgical Resection Does, Urology, Surgical Oncology +7

Impact of contemporary patterns of chemotherapy utilization on survival in patients with advanced cancer of the urinary tract: a Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)

Aristotelis Bamias, Kimon Tzannis, L.C. Harshman et al. · Annals of Oncology · 2017 · 71 citations · Full text

Surgical Oncology, Urology, Urologic Cancer Epidemiology +9

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC)

Andrea Necchi, Guru Sonpavde, Salvatore Lo Vullo et al. · European Urology · 2016 · 66 citations · Full text

Urology, Overall Survival, Genitourinary Cancer +6